Ironwood Pharmaceuticals (IRWD) Minority Interest (2023)
Ironwood Pharmaceuticals' (IRWD) quarterly Minority Interest came in at -$2.5 million in Q3 2023, down 129.54% quarter-over-quarter from -$1.1 million in Q2 2023.
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Minority Interest (2023) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Minority Interest across 1 years of filings, most recently posting -$2.5 million for Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - |